We are live on ! Find out more

59 hedge funds and large institutions have $110M invested in CareDx in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

640% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 5

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

293% more capital invested

Capital invested by funds: $28M → $110M (+$82M)

200% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 5

119% more funds holding

Funds holding: 2759 (+32)

23.02% more ownership

Funds ownership: 29.36%52.38% (+23%)

Holders
59
Holders Change
+32
Holders Change %
+118.52%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
37
Increased
15
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change

CDNA Hedge Fund Activity: Q4 2017 in Review

59 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q4 2017, worth a combined $110M — up 293% from $28M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new CDNA positions and 5 closed out — a net gain of 32 holders — while 15 added to existing stakes and 5 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $7.72M. The largest seller was Paragon Associates & Paragon Associates II Joint Venture, cutting an estimated $2.03M.

  • 59 institutional investors held CareDx (CDNA) as of Q4 2017, up from 27 in Q3 2017.
  • Funds reported $110M of CareDx stock for Q4 2017, up 293% quarter-over-quarter.
  • 37 funds opened new CareDx positions in Q4 2017 and 5 closed out, a net change of +32 holders.
  • The largest CareDx buyer in Q4 2017 was Fred Alger Management, an estimated $7.72M added.
  • The largest CareDx seller in Q4 2017 was Paragon Associates & Paragon Associates II Joint Venture, an estimated $2.03M sold.

Based on aggregated 13F filings for Q4 2017.